FN1 and colorectal carcinoma: Additionally, Fn and its metabolite, succinic acid, can inhibit anti-tumor responses, causing CRC to develop resistance to immunotherapy and chemotherapy by avoiding apoptosis (Jiang et al., 2023; Lu et al., 2019).